TENAYA THERAPEUTICS INC (TNYA) Stock Analyst Earnings Estimates
NASDAQ:TNYA - Nasdaq - US87990A1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 5,222.55% | N/A 130.09% | N/A 158.58% | N/A 79.26% | N/A 44.08% | N/A 72.94% | |||||||
| EBITDA YoY % growth | -25.72M | -36.43M -41.64% | -69.85M -91.74% | -119.15M -70.58% | -122.506M -2.82% | -107.48M 12.27% | N/A 10.79% | N/A -8.90% | N/A -15.69% | N/A -56.46% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.71M | -38.91M -40.42% | -72.81M -87.12% | -125.62M -72.53% | -131.193M -4.44% | -115.948M 11.62% | N/A 10.07% | N/A -4.31% | N/A 92.56% | N/A 4,001.29% | N/A 227.40% | N/A 86.06% | N/A 51.98% | N/A 84.05% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.79 70.82% | -1.67 40.14% | -1.32 20.96% | N/A 38.95% | N/A 10.67% | N/A 106.52% | N/A 4,153.70% | N/A 169.84% | N/A 74.72% | N/A 92.95% | N/A 14.61% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 45.98% | -0.16 41.31% | -0.26 -6.25% | -0.38 -173.21% | -0.40 -148.60% | -0.41 -151.38% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -26.622M -30.94% | -29.682M -83.40% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.266M 1.67% | -25.471M -3.32% | -25.16M 8.63% | -42.591M -76.86% | -45.358M -72.69% | -50.897M -99.82% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.14 58.82% | -0.26 | 0.11 | 45.10% |
| Q1 2025 Q2Q % growth | -0.24 40.00% | -0.19 | -0.05 | -23.84% |
| Q4 2024 Q2Q % growth | -0.28 30.00% | -0.32 | 0.04 | 11.76% |
| Q3 2024 Q2Q % growth | -0.30 23.08% | -0.37 | 0.07 | 19.97% |
| Q2 2024 Q2Q % growth | -0.34 24.44% | -0.40 | 0.06 | 14.77% |
| Q1 2024 Q2Q % growth | -0.40 6.98% | -0.43 | 0.03 | 7.26% |
| Q4 2023 Q2Q % growth | -0.40 34.43% | -0.45 | 0.05 | 10.62% |
| Q3 2023 Q2Q % growth | -0.39 47.30% | -0.48 | 0.09 | 19.14% |
| Q2 2023 Q2Q % growth | -0.45 34.78% | -0.51 | 0.06 | 12.35% |
| Q1 2023 Q2Q % growth | -0.43 42.67% | -0.57 | 0.14 | 25.16% |
| Q4 2022 Q2Q % growth | -0.61 3.17% | -0.66 | 0.05 | 7.99% |
| Q3 2022 Q2Q % growth | -0.74 -8.82% | -0.65 | -0.09 | -13.06% |
| Q2 2022 Q2Q % growth | -0.69 94.80% | -0.77 | 0.08 | 10.76% |
| Q1 2022 Q2Q % growth | -0.75 | -0.66 | -0.09 | -14.00% |
| Q4 2021 Q2Q % growth | -0.63 | -0.62 | -0.01 | -2.09% |
| Q3 2021 Q2Q % growth | -0.68 | -0.72 | 0.04 | 5.44% |
| Q2 2021 Q2Q % growth | -13.26 | -7.32 | -5.94 | -81.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.5% | -47.06% | 0% | -11.44% |
| Revenue | N/A | N/A | N/A | -100% |